http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0206287-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d65a4b08cf5d968a6fe9122e1dd6eca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0db67bf9d099ba35e4504d7595be304c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_087bed7abab91ae0f927879f9fe8b273 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 |
filingDate | 2001-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f57d87310ab04fade973053690a7092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a894e6a9ff55a26b9dc53561de2a39 |
publicationDate | 2002-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-0206287-A3 |
titleOfInvention | Macrocyclic mri contrast agents |
abstract | The invention relates to novel magnetic resonance imaging contrast agents of Formula: (I) wherein A-B is a structure selected from the group consisting of -CR2-CR2-, -CR=CR-, -CR2-CR2-CR2-, CR=CR-CR2- and -CR2-CR=CR; X?1 and X2¿ are independently selected from the group consisting of CR¿2? COO, CR2COOH, CR(CR2COO)2, CR(CR2COOH)2; each R is independently selected from the group consisting of hydrogen, alkyl, aryl, alcohol, amine, amido, nitro, ether, ester, ketone, imino, aldehyde, alkoxy, carbonyl, halogen, sulfur containing moiety, phosphorus containing moiety, targeting moiety, moiety, or, together with an adjacent R group forms an alkyl or aryl group. |
priorityDate | 2000-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.